ASML

1,176.4

+3.5%↑

SAP

153.12

-0.04%↓

IFX

38.3

+2.54%↑

NOKIA.FI

6.84

-1.72%↓

STMPA.FR

26.99

+0.15%↑

ASML

1,176.4

+3.5%↑

SAP

153.12

-0.04%↓

IFX

38.3

+2.54%↑

NOKIA.FI

6.84

-1.72%↓

STMPA.FR

26.99

+0.15%↑

ASML

1,176.4

+3.5%↑

SAP

153.12

-0.04%↓

IFX

38.3

+2.54%↑

NOKIA.FI

6.84

-1.72%↓

STMPA.FR

26.99

+0.15%↑

ASML

1,176.4

+3.5%↑

SAP

153.12

-0.04%↓

IFX

38.3

+2.54%↑

NOKIA.FI

6.84

-1.72%↓

STMPA.FR

26.99

+0.15%↑

ASML

1,176.4

+3.5%↑

SAP

153.12

-0.04%↓

IFX

38.3

+2.54%↑

NOKIA.FI

6.84

-1.72%↓

STMPA.FR

26.99

+0.15%↑

Home・Aandelen Lijst・GFT Technologies SE

G
GFT Technologies SE

Gesloten

17.22 -2.38

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.82

Max

17.88

Belangrijke statistieken
By Trading Economics
Inkomsten	2.5M 8.9M
Verkoop	19M 233M
K/W Sectorgemiddelde	13.015 77.27
EPS	0.338
Dividendrendement	2.79
Winstmarge	4.161
Werknemers	11,772
EBITDA	-636M -616M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+58.19% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	2.79% 2.29%
Volgende Winsten	27 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	64M 459M
Vorige openingsprijs	19.6
Vorige sluitingsprijs	17.22

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

22.6 / 24.8 Steun & Weerstand

GFT Technologies SE Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Winsten

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

GFT Technologies SE Prognose

Koersdoel

By TipRanks

58.19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 28 EUR 58.19%

Hoogste 32 EUR

Laagste 24 EUR

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor GFT Technologies SE - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan GFT Technologies SE - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

22.6 / 24.8Steun & Weerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over GFT Technologies SE

GFT Technologies SE, together with its subsidiaries, provides digital transformation services. The company operates in two segments in the Americas, the UK & APAC; and Continental Europe. It offers consulting on the development and implementation of IT strategies; development of bespoke IT solutions; implementation of sector-specific software; and maintenance and development of business-critical IT solutions. The company serves clients in investment and retail banking, insurance, and industrial sectors. It operates in Brazil, Germany, France, the United Kingdom, Hong Kong, Italy, Canada, Mexico, Poland, Switzerland, Singapore, Spain, the United States, and internationally. GFT Technologies SE was founded in 1987 and is headquartered in Stuttgart, Germany.